Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeeing Machines Regulatory News (SEE)

Share Price Information for Seeing Machines (SEE)

Share Price is delayed by 15 minutes
Get Live Data
4.815    0.11 (2.34%)
Bid:
4.755
Ask:
4.80
Spread: 0.045 (0.946%)
Market Cap: £231.10m
SEE Live PriceLast checked at - London Stock Exchange

Intraday Seeing Machines Share Chart

Joint Venture created

15 Oct 2014 07:00

RNS Number : 2667U
Seeing Machines Limited
15 October 2014
 



Seeing Machines and Australian National University Sign Truefield Joint Venture

New entity created to commercialise ophthalmic-research IP

 

15 October 2014

 

Seeing Machines Limited (AIM: SEE), the AIM listed technology company with a focus on operator monitoring and intervention sensing technologies and services, is proud to announce the formation of a new joint venture, NuCoria Pty. Ltd., with The Australian National University (ANU) to commercialise TrueField Analyzer (TFA) Intellectual Property. Leveraging Seeing Machines' patented IP, technical expertise, and ANU's technology transfer & commercialisation successes, NuCoria will be dedicated to bringing revolutionary medical devices to market.

The TrueField Analyzer was originally developed collaboratively between ANU and Seeing Machines, and each of them has licensed their relevant existing intellectual property to NuCoria. NuCoria is a strategic arrangement that allows Seeing Machines to focus on core opportunities and competencies, including its alliances with Caterpillar Global Mining and TK Holdings (part of the Takata Group) and other rapidly emerging transport sector opportunities. ANU, following its own successful sale of Lithicon for A$76m, will take the lead in managing, staffing, and funding NuCoria. Seeing Machines will have an initial interest of 18% of NuCoria, will nominate a non-executive director and will receive royalties from any future licensing deals the new Company enters into.

NuCoria will become the primary vehicle for emerging ophthalmic-technology IP from ANU research centres. Professor Ted Maddess, TFA inventor and Director of the ARC Centre of Excellence in Vision Science, said: "We have been working with Seeing Machines to produce a rapid non-contact objective way of mapping the visual fields of both eyes at the same time. We have now published 17 studies showing that the new method has utility for the top three blinding diseases: glaucoma, macular degeneration and diabetic retinopathy, and also for some neurological disorders. The method continues to evolve and improve."

Ken Kroeger, CEO of Seeing Machines, said: "This is a fantastic outcome for all parties. Our company's DNA & legacy is closely tied with the ANU, hence I firmly believe that they are the right partners to move forward with this exciting technology. While the core focus of Seeing Machines is to save lives with our Driver Safety System (DSS) in the mining and road-transport industries, being able to work with strategic partners in exciting applications of our core-technology is part-and-parcel of how we operate."

Michael Cardew-Hall, ANU Pro-Vice Chancellor of Innovation and Advancement, said: "This is an exciting development in commercialisation of the TrueField Analyzer technology. The ANU has been committed to partnering with Seeing Machines in the development of the TrueField IP which was originally generated from research at the University. We believe that it has the potential to have significant benefits in the area of ophthalmology. The links between ANU and Seeing Machines are long standing, with it originally being a start up from the University itself. The NuCoria collaboration brings the expertise of Seeing Machines and ANU together to take this technology to market."

_______________________________________

 

Enquiries:

Seeing Machines Limited

www.seeingmachines.com

Ken Kroeger, Managing Director and CEO

+61 2 6103 4700

Ken.Kroeger@seeingmachines.com

James Walker, Finance Director

+61 2 6103 4700

James.Walker@seeingmachines.com

finnCap Ltd, Broker for Seeing Machines

Ed Frisby / Ben ThompsonCorporate Finance

+44 20 7220 0500

Victoria BatesCorporate Broking

Newgate Threadneedle, Investment Communications for Seeing Machines

Robyn McConnachie

 

 

Josh Royston

Tel: +44 20 7653 9852

Mob: +44 7540 706 191

r.mcconnachie@newgatethreadneedle.com

Tel: +44 20 7653 9844

Mob: +44 7789 003 223

j.royston@newgatethreadneedle.com

About Seeing Machines

Seeing Machines, (AIM: SEE), is an AIM-listed technology company that specialises in operator monitoring and intervention technologies and services. Its software and engineering services are used in products and applications that range from devices that improve driver safety and save lives to assessing trainees in simulators and simplifying the relationships between people and technology. Seeing Machines technology is used worldwide across the automotive, mining, transport and aviation industries; as well as many of the leading academic research groups and transportation authorities. Seeing Machines is headquartered in Australia, and has offices in Tucson, Arizona and Mountain View, California. The Company counts Caterpillar, Takata and Eye Tracking Inc as its partners and BHP Billiton, Freeport McMoran, Teck, Toll Holdings amongst its customers.

 

About The Australian National University

The Australian National University was established in 1946 to support the development of national unity and identity, to improve Australia's understanding of itself and its neighbours, and to contribute to economic development and social cohesion. ANU is a celebrated place of intensive research, education and policy engagement - setting the standard on issues of national and international importance. Its body of students is drawn from across the nation and around the world. ANU is a global university that consistently ranks amongst the world's finest educational institutions, and is a centre of unparalleled intellectual talent and research excellence. The University's research has been involved in the creation of a number of successful spin-off companies, including Seeing Machines, Beta Therapeutics and Lithicon.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAMIBTTMBIBBTI
Date   Source Headline
31st Mar 20257:00 amRNSDirector/PDMR Shareholding
28th Mar 20257:00 amRNSDirector/PDMR Shareholding
27th Mar 20257:11 amRNSBoard Changes
27th Mar 20257:08 amRNSHalf year results and financial report
26th Mar 20258:15 amRNSHolding(s) in Company
24th Mar 20257:00 amRNS-RNew Technology and Safety Leadership Appointments
21st Mar 20257:59 amRNSLondon Town Hall presentation to be live streamed
3rd Mar 202510:18 amRNSNotification of Major Holdings
27th Feb 20257:00 amRNSDirector/PDMR Shareholding
26th Feb 20257:00 amRNSH1 FY2025 Trading Update & Quarterly KPIs
24th Feb 20257:00 amRNSMitsubishi Electric Automotive America Agreement
18th Feb 20257:00 amRNSLondon Presentation
23rd Jan 20257:00 amRNSDirector dealing
21st Jan 20257:00 amRNSDirector/PDMR Shareholding
20th Jan 20257:00 amRNSDirector/PDMR Shareholding
15th Jan 20257:00 amRNSDirector/PDMR Shareholding
15th Jan 20257:00 amRNSDirector/PDMR Shareholding
14th Jan 20257:11 amRNSDirector/PDMR Shareholding
10th Jan 20257:00 amRNSPDMR / Director Dealing
3rd Jan 20257:00 amRNSHolding(s) in Company
31st Dec 202412:27 pmRNSHolding(s) in Company
31st Dec 20248:00 amRNSHolding(s) in Company
31st Dec 20248:00 amRNSPDMR/PCA Dealing
31st Dec 20248:00 amRNSDirector/PDMR Shareholding
31st Dec 20248:00 amRNSDirector/PDMR Shareholding
30th Dec 20247:00 amRNSHolding(s) in Company
30th Dec 20247:00 amRNSDirector/PDMR Shareholding
23rd Dec 20247:00 amRNS£26.2 million strategic investment from Mitsubishi
19th Dec 20247:00 amRNSIssue of Equity and Total Voting Rights
12th Dec 20243:00 pmRNSFY2024 Annual Report
4th Dec 20247:00 amRNS-RLaunch of 2023-24 Guardian Insights Report
27th Nov 20248:49 amRNSResult of AGM
21st Nov 20248:30 amRNSIssue of Shares and Total Voting Rights
11th Nov 20247:00 amRNSQ1 FY2025 Quarterly KPIs
4th Nov 20247:00 amRNSNotice of Annual General Meeting
31st Oct 20247:00 amRNSGlobal regulatory momentum drives revenue growth
17th Oct 20247:00 amRNSNotice of Full Year Results 2024
28th Aug 20247:00 amRNSSeeing Machines FY24 Trading Update
8th Aug 20247:00 amRNSSeeing Machines (SEE) Q4 FY2024 Quarterly KPIs
8th Jul 20247:00 amRNSSeeing Machines acquires Asaphus Vision GmbH
26th Jun 20247:00 amRNSFive year License Renewal with Caterpillar
7th May 20247:00 amRNSQ3 FY2024 Quarterly KPIs
2nd May 202410:30 amRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSAutomotive Program Extension to 2032
26th Apr 202411:00 amRNSDirector/PDMR Shareholding
25th Mar 20248:06 amRNSDirector/PDMR Shareholding
18th Mar 20247:00 amRNSHalf year results and financial report
28th Feb 20247:00 amRNSNotice of Results
8th Feb 20247:00 amRNSH1 FY2024 Trading Update & Quarterly KPIs
10th Jan 20247:00 amRNSNew Orders for Guardian Generation 3

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.